(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with benextramine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, JR | 1 |
1 other study(ies) available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and benextramine
| Article | Year |
|---|---|
Pressor effect of the putative M1 muscarinic receptor agonist MCN-A-343 in the conscious rat.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Adrenal Medulla; Adrenergic Agonists; Adrenergic Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cystamine; Drug Interactions; Guanethidine; Male; Muscarinic Agonists; Neuropeptide Y; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Yohimbine | 1996 |